Navigation Links
Kentucky researchers find a key to plant disease resistance
Date:3/28/2011

LEXINGTON, Ky., (March 28, 2011) University of Kentucky plant pathologists recently discovered a metabolite that plays a critical role early on in the ability of plants, animals, humans and one-celled microorganisms to fend off a wide range of pathogens at the cellular level, which is known as systemic immunity. This mode of resistance has been known for more than 100 years, but the key events that stimulate that resistance have remained a mystery.

The findings of the UK College of Agriculture researchers, led by Pradeep Kachroo and Aardra Kachroo, were published online in Nature Genetics March 27. Researchers from the UK Department of Statistics and Washington State University also contributed to the article.

"If you can generate systemic immunity, you can have great benefits in disease resistance," Pradeep Kachroo said. "It is particularly gratifying to be able to describe a mechanism for a type of immunity; pioneering studies were incidentally carried out by our own emeritus faculty, Joe Kuc."

Using soybeans and Arabidopsis, a model laboratory plant, the scientists were able to identify the metabolite glycerol-3-phosphate as a key mobile regulator of systemic immunity. A metabolite is a substance produced in the body through normal metabolic processes. The glycerol-3-phosphate transforms into an unknown compound and uses a protein, called DIR1 to signal systemic immunity. Scientists already identified the protein as a necessary component to trigger systemic immunity.

"The metabolite and protein are dependent on each other to transport immunity from one location in the plant tissue to the other," Pradeep Kachroo said. "Metabolite levels increase in plant tissues after the plant has been inoculated by a pathogen."

While the research was conducted on plants, Pradeep Kachroo said all organisms have a similar process of triggering systemic immunity.

"The metabolite is a highly conserved compound in all species across the board," Pradeep Kachroo said. "Another great thing is increased levels of this metabolite do not affect plant productivity, unlike other known inducers of systemic immunity."

He said the metabolite could be an effective tool to control plant diseases and enhance pathogen tolerance in plants.

In 2008, these UK plant pathologists discovered that the same metabolite was a key component in organisms' basal resistance, which allows organisms to have strong immune systems. They wondered whether there was a connection between the metabolite and systemic immunity, which led them to their current research.

Their research was funded by the National Science Foundation's Division of Integrative Organismal Systems. The plant pathologists will continue to study the process that induces systemic immunity.

"We want to know how glycerol-3-phosphate is metabolized in plants and identify various compounds derived from glycerol-3-phosphate," Pradeep Kachroo said. "We also want to know how the metabolite relates other molecules known to be important for systemic immunity."


'/>"/>

Contact: Katie Pratt
859-257-8774
University of Kentucky
Source:Eurekalert

Related biology news :

1. Kentucky study advances new target for CNS drug development
2. Researchers unlock new secret to how smells are detected
3. RIT researchers help map tsunami and earthquake damage in Japan
4. Dont shuffle on slippery surfaces, Clemson University, Charleston researchers say
5. U of M researchers close in on technology for making renewable petroleum
6. Heinz Maier-Leibnitz Prizes 2011: Recognition and incentive for early career researchers
7. MU researchers use motion sensors to determine equine lameness
8. PMH researchers create an organic nanoparticle that uses sound and heat to find and treat tumors
9. Researchers step closer to treatment of virulent hospital infection
10. UCLA researchers engineer E. coli to produce record-setting amounts of alternative fuel
11. Hopkins researchers use light to move molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: